{"id":391203,"title":"Terms of Reference: Expert Advisory Panel on the use of Avastin in Metastatic Breast Cancer (EAP-AmBC) - Health Canada - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-04-14","captureTimestamp":"2026-04-14T04:01:22.426000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/activities/scientific-expert-advisory-panels/avastin/terms-reference-avastin-metastatic-breast-cancer.html","snippet":"Terms of Reference: Expert Advisory Panel on the use of Avastin in Metastatic Breast Cancer (EAP-AmBC) - Health Canada The Biologics and Genetic Therapies Directorate's (BGTD) Expert Advisory Panel on the Use of AVASTIN™ in Metastatic Breast Cancer (EAP-AmBC) is being established…","rawSnapshotUrl":"/api/snapshots/raw/391203","browseUrl":"https://replay.healtharchive.ca/job-6/20260414040122/https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/activities/scientific-expert-advisory-panels/avastin/terms-reference-avastin-metastatic-breast-cancer.html#ha_snapshot=391203","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}